Zheng Feng
Head, Clinical Genomics, Global Clinical Biomarkers & Companion Diagnostics EMD Serono
Seminars
Wednesday 22nd July 2026
Right Test, Right Setting: Balancing Cost, Feasibility & Fit-for-Purpose in Liquid Biopsies
2:45 pm
- How clinical use case, risk tolerance, and decision impact should dictate assay design, validation depth, and deployment setting across screening, MRD, and treatment monitoring
- Practical trade-offs between analytical performance, cost, turnaround time, infrastructure, and scalability when moving liquid biopsy tools from trials into routine practice
- Where AI can meaningfully enhance liquid biopsy workflows, and where added model complexity creates validation, regulatory, or adoption challenges without clear clinical gain
Wednesday 22nd July 2026
Panel Discussion: Integrating Emerging Diagnostic Technologies to Enable Faster, More Informed Clinical Development
4:30 pm
- How to integrate emerging diagnostics, including liquid biopsy, with complimentary modalities to generate earlier, higher confidence clinical signals
- What is required to make these technologies decision-grade at scale, including validation, standardization, and operational workflows
- Where integration most accelerates development, improving patient selection, response monitoring, and resistance insight to deliver better therapies faster
